Latest Insider Transactions at Computer Programs & Systems Inc (CPSI)
This section provides a real-time view of insider transactions for Computer Programs & Systems Inc (CPSI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of COMPUTER PROGRAMS & SYSTEMS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of COMPUTER PROGRAMS & SYSTEMS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.47%
|
$230,000
$23.0 P/Share
|
|
Dec 02
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
45,000
+2.08%
|
$990,000
$22.72 P/Share
|
|
Dec 01
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
75,000
+3.49%
|
$1,650,000
$22.4 P/Share
|
|
Nov 19
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,501
+0.99%
|
$170,020
$20.7 P/Share
|
|
Nov 18
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,639
+0.43%
|
$72,780
$20.84 P/Share
|
|
Nov 17
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,707
+2.41%
|
$414,140
$20.42 P/Share
|
|
Nov 17
2025
|
Michael Daughton Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
17,500
+23.34%
|
$350,000
$20.46 P/Share
|
|
Nov 14
2025
|
Michael Daughton Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+5.88%
|
$50,000
$20.15 P/Share
|
|
Nov 14
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
18,933
+2.26%
|
$378,660
$20.23 P/Share
|
|
Nov 13
2025
|
Michael Daughton Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
4,354
+10.4%
|
$87,080
$20.16 P/Share
|
|
Nov 13
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
21,035
+2.57%
|
$420,700
$20.41 P/Share
|
|
Nov 12
2025
|
Michael Daughton Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
10,167
+23.48%
|
$193,173
$19.95 P/Share
|
|
Nov 12
2025
|
Pinetree Capital Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,935
+1.14%
|
$169,765
$19.94 P/Share
|
|
Nov 11
2025
|
Michael Daughton Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
15,479
+40.26%
|
$294,101
$19.39 P/Share
|
|
Oct 15
2025
|
Michael Daughton Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,492
+50.0%
|
-
|
|
Jul 01
2025
|
Christopher L Fowler President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,278
-1.76%
|
$52,394
$23.48 P/Share
|
|
May 23
2025
|
L6 Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,000
+1.23%
|
$600,000
$24.01 P/Share
|
|
May 22
2025
|
L6 Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,000
+0.75%
|
$345,000
$23.98 P/Share
|
|
May 21
2025
|
L6 Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,000
+2.0%
|
$960,000
$24.3 P/Share
|
|
May 20
2025
|
Vita Mac Intyre Controller |
SELL
Open market or private sale
|
Direct |
335
-13.81%
|
$8,040
$24.94 P/Share
|
|
May 16
2025
|
Christopher L Fowler President and CEO |
SELL
Open market or private sale
|
Direct |
6,000
-4.38%
|
$150,000
$25.05 P/Share
|
|
Mar 27
2025
|
Vita Mac Intyre Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
188
-7.19%
|
$5,264
$28.53 P/Share
|
|
Mar 21
2025
|
L6 Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
31,083
+1.59%
|
$839,241
$27.99 P/Share
|
|
Mar 19
2025
|
L6 Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
65,524
+3.34%
|
$1,703,624
$26.93 P/Share
|
|
Mar 17
2025
|
Dawn M Severance Chief Sales Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,122
-3.54%
|
$31,416
$28.1 P/Share
|
|
Mar 17
2025
|
Vinay Bassi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,965
-8.35%
|
$111,020
$28.1 P/Share
|
|
Mar 17
2025
|
David Harse General Manager Patient Care |
SELL
Payment of exercise price or tax liability
|
Direct |
1,098
-5.25%
|
$30,744
$28.1 P/Share
|
|
Mar 17
2025
|
Kevin Plessner General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
798
-5.6%
|
$22,344
$28.1 P/Share
|
|
Mar 17
2025
|
Christopher L Fowler President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,849
-4.09%
|
$163,772
$28.1 P/Share
|
|
Mar 14
2025
|
David Harse General Manager Patient Care |
SELL
Open market or private sale
|
Direct |
1,744
-8.81%
|
$47,088
$27.4 P/Share
|
|
Mar 14
2025
|
Christopher L Fowler President and CEO |
SELL
Open market or private sale
|
Direct |
5,100
-3.45%
|
$137,700
$27.02 P/Share
|
|
Mar 13
2025
|
Regina M. Benjamin Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+10.16%
|
-
|
|
Mar 13
2025
|
Mark V Anquillare Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+16.88%
|
-
|
|
Mar 13
2025
|
Amy K O'Keefe Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+36.66%
|
-
|
|
Mar 13
2025
|
Christopher T Hjelm Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+12.17%
|
-
|
|
Mar 13
2025
|
David A Dye Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+4.25%
|
-
|
|
Mar 13
2025
|
Jerry G Canada Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+50.0%
|
-
|
|
Mar 13
2025
|
Vinay Bassi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,588
+23.5%
|
-
|
|
Mar 13
2025
|
Glenn Tobin Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+7.95%
|
-
|
|
Mar 13
2025
|
Kevin Plessner General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,985
+17.31%
|
-
|
|
Mar 13
2025
|
Vita Mac Intyre Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,044
+28.55%
|
-
|
|
Mar 13
2025
|
David Harse General Manager Patient Care |
BUY
Grant, award, or other acquisition
|
Direct |
5,835
+21.83%
|
-
|
|
Mar 13
2025
|
Christopher L Fowler President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,611
+13.25%
|
-
|
|
Mar 13
2025
|
Andris Upitis Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,376
+50.0%
|
-
|
|
Mar 13
2025
|
Merideth Wilson Financial Health GM |
BUY
Grant, award, or other acquisition
|
Direct |
5,981
+50.0%
|
-
|
|
Mar 13
2025
|
Dawn M Severance Chief Sales Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,055
+13.75%
|
-
|
|
Mar 07
2025
|
Dawn M Severance Chief Sales Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
714
-1.31%
|
$19,992
$28.3 P/Share
|
|
Mar 07
2025
|
Christopher L Fowler President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,883
-1.13%
|
$80,724
$28.3 P/Share
|
|
Mar 07
2025
|
Kevin Plessner General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-2.22%
|
$14,476
$28.3 P/Share
|
|
Feb 25
2025
|
L6 Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
87,232
+4.55%
|
$2,442,496
$28.09 P/Share
|